vs
New Fortress Energy Inc.（NFE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是New Fortress Energy Inc.的1.9倍（$622.0M vs $326.2M），Royalty Pharma plc净利率更高（34.4% vs -259.7%，领先294.1%），Royalty Pharma plc同比增速更快（4.8% vs -7.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -26.8%）
New Fortress Energy Inc.是一家全球能源基础设施企业，主要开发、持有并运营液化天然气进出口终端、天然气供应网络及低碳能源项目，服务美洲、加勒比地区客户，致力于提供低成本、低排放的能源解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
NFE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$326.2M
营收增速更快
RPRX
高出11.8%
-7.0%
净利率更高
RPRX
高出294.1%
-259.7%
两年增速更快
RPRX
近两年复合增速
-26.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.2M | $622.0M |
| 净利润 | $-847.1M | $214.2M |
| 毛利率 | 35.5% | — |
| 营业利润率 | -193.0% | 62.4% |
| 净利率 | -259.7% | 34.4% |
| 营收同比 | -7.0% | 4.8% |
| 净利润同比 | -277.4% | 2.9% |
| 每股收益（稀释后） | $-3.03 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NFERPRX
| Q4 25 | $326.2M | $622.0M | ||
| Q3 25 | $240.3M | $609.3M | ||
| Q2 25 | $228.1M | $578.7M | ||
| Q1 25 | $384.9M | $568.2M | ||
| Q4 24 | $350.7M | $593.6M | ||
| Q3 24 | $446.0M | $564.7M | ||
| Q2 24 | $291.2M | $537.3M | ||
| Q1 24 | $609.5M | $568.0M |
净利润NFERPRX
| Q4 25 | $-847.1M | $214.2M | ||
| Q3 25 | $-263.0M | $288.2M | ||
| Q2 25 | $-546.5M | $30.2M | ||
| Q1 25 | $-175.4M | $238.3M | ||
| Q4 24 | $-224.4M | $208.2M | ||
| Q3 24 | $9.3M | $544.0M | ||
| Q2 24 | $-88.9M | $102.0M | ||
| Q1 24 | $54.1M | $4.8M |
毛利率NFERPRX
| Q4 25 | 35.5% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 17.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 23.8% | — | ||
| Q1 24 | 62.4% | — |
营业利润率NFERPRX
| Q4 25 | -193.0% | 62.4% | ||
| Q3 25 | -37.4% | 70.1% | ||
| Q2 25 | -170.3% | 36.3% | ||
| Q1 25 | -3.3% | 94.0% | ||
| Q4 24 | 65.0% | 60.9% | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | 12.3% | 50.2% | ||
| Q1 24 | 30.4% | -13.0% |
净利率NFERPRX
| Q4 25 | -259.7% | 34.4% | ||
| Q3 25 | -109.4% | 47.3% | ||
| Q2 25 | -239.6% | 5.2% | ||
| Q1 25 | -45.6% | 41.9% | ||
| Q4 24 | -64.0% | 35.1% | ||
| Q3 24 | 2.1% | 96.3% | ||
| Q2 24 | -30.5% | 19.0% | ||
| Q1 24 | 8.9% | 0.8% |
每股收益（稀释后）NFERPRX
| Q4 25 | $-3.03 | $0.49 | ||
| Q3 25 | $-0.96 | $0.67 | ||
| Q2 25 | $-1.99 | $0.07 | ||
| Q1 25 | $-0.65 | $0.55 | ||
| Q4 24 | $-1.10 | $0.46 | ||
| Q3 24 | $0.03 | $1.21 | ||
| Q2 24 | $-0.42 | $0.23 | ||
| Q1 24 | $0.23 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $226.5M | $618.7M |
| 总债务越低越好 | $8.2B | $9.0B |
| 股东权益账面价值 | $182.6M | $9.7B |
| 总资产 | $10.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 44.78× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资NFERPRX
| Q4 25 | $226.5M | $618.7M | ||
| Q3 25 | $145.2M | $938.9M | ||
| Q2 25 | $551.1M | $631.9M | ||
| Q1 25 | $447.9M | $1.1B | ||
| Q4 24 | $492.9M | $929.0M | ||
| Q3 24 | $90.8M | $950.1M | ||
| Q2 24 | $133.0M | $1.8B | ||
| Q1 24 | $143.5M | $843.0M |
总债务NFERPRX
| Q4 25 | $8.2B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $8.9B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益NFERPRX
| Q4 25 | $182.6M | $9.7B | ||
| Q3 25 | $1.1B | $9.6B | ||
| Q2 25 | $1.3B | $9.5B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.9B | $10.3B | ||
| Q3 24 | $1.6B | $10.3B | ||
| Q2 24 | $1.6B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
总资产NFERPRX
| Q4 25 | $10.6B | $19.6B | ||
| Q3 25 | $12.0B | $19.3B | ||
| Q2 25 | $12.0B | $18.3B | ||
| Q1 25 | $13.1B | $17.6B | ||
| Q4 24 | $12.9B | $18.2B | ||
| Q3 24 | $12.0B | $18.0B | ||
| Q2 24 | $11.4B | $17.7B | ||
| Q1 24 | $10.9B | $16.1B |
负债/权益比NFERPRX
| Q4 25 | 44.78× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 4.74× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-76.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-134.8M | — |
| 自由现金流率自由现金流/营收 | -41.3% | — |
| 资本支出强度资本支出/营收 | 18.0% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-1.4B | — |
8季度趋势，按日历期对齐
经营现金流NFERPRX
| Q4 25 | $-76.2M | $827.1M | ||
| Q3 25 | $-171.0M | $702.6M | ||
| Q2 25 | $-329.0M | $364.0M | ||
| Q1 25 | $-7.2M | $596.1M | ||
| Q4 24 | $445.3M | $742.5M | ||
| Q3 24 | $-20.0M | $703.6M | ||
| Q2 24 | $113.9M | $658.2M | ||
| Q1 24 | $63.0M | $664.6M |
自由现金流NFERPRX
| Q4 25 | $-134.8M | — | ||
| Q3 25 | $-231.6M | — | ||
| Q2 25 | $-726.7M | — | ||
| Q1 25 | $-262.3M | — | ||
| Q4 24 | $-210.3M | — | ||
| Q3 24 | $-367.0M | — | ||
| Q2 24 | $-493.2M | — | ||
| Q1 24 | $-457.9M | — |
自由现金流率NFERPRX
| Q4 25 | -41.3% | — | ||
| Q3 25 | -96.4% | — | ||
| Q2 25 | -318.6% | — | ||
| Q1 25 | -68.2% | — | ||
| Q4 24 | -60.0% | — | ||
| Q3 24 | -82.3% | — | ||
| Q2 24 | -169.3% | — | ||
| Q1 24 | -75.1% | — |
资本支出强度NFERPRX
| Q4 25 | 18.0% | — | ||
| Q3 25 | 25.2% | — | ||
| Q2 25 | 174.4% | — | ||
| Q1 25 | 66.3% | — | ||
| Q4 24 | 187.0% | — | ||
| Q3 24 | 77.8% | — | ||
| Q2 24 | 208.4% | — | ||
| Q1 24 | 85.5% | — |
现金转化率NFERPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | -2.15× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 1.16× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NFE
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
